The Hydration Pharmaceuticals Company Limited
HPC.AX
Australian Securities Exchange0.00
AUD
- -
- -
The Hydration Pharmaceuticals Company Limited
HPC.AX
(Australian Securities Exchange)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- The Hydration Pharmaceuticals Company Limited (ASX:HPC) markets and distributes healthy hydration products under the Hydralyte brand, including liquid solutions, effervescent tablets, and powder formulations designed for electrolyte replenishment and consumer healthcare needs such as hydration support, immune system support, energy support, liver support, metabolic support, gut barrier support, hair growth, stronger nails, and decreased wrinkle depth; these products feature premium, gluten-free, non-GMO ingredients and are sold through wholesale suppliers, online retailers, and retail stores. The company, founded in 2001 and headquartered in Melbourne, Australia, primarily focuses on the North American market, particularly the United States and Canada, following the divestment of its non-US business and assets to Prestige Consumer Healthcare Inc. for A$13.7 million in October 2024, which enabled full debt repayment and provision of capital for US growth initiatives; it holds distribution rights to Hydralyte globally outside Australia, New Zealand, Asia (excluding China, including Hong Kong but excluding Taiwan), Africa, and the Middle East (excluding Turkey). Recent developments include execution of a variation to its facility agreement with PURE Asset Management for A$1.7 million in new funding to support a potential sale transaction, leadership changes with Oliver Baker appointed as CEO and Managing Director in May 2024 alongside Nicholas Berry and continued service by Chairman Adem Karafili, and director share purchases such as Joseph Constable's acquisition of shares in June 2025; the firm operates in the consumer staples sector's personal products segment, targeting health-conscious consumers seeking oral rehydration solutions.